Format

Send to

Choose Destination
Anal Biochem. 2008 Jun 15;377(2):267-9. doi: 10.1016/j.ab.2008.03.028. Epub 2008 Mar 22.

Development and optimization of a binding assay for histone deacetylase 4 using surface plasmon resonance.

Author information

1
Istituto di Ricerche di Biologia Molecolare P. Angeletti, Via Pontina Km 30.600, 00040 Pomezia (Rome), Italy. marco_mattu@merck.com

Abstract

Histone deacetylase 4 (HDAC4) is a histone deacetylase profoundly involved in cell differentiation and in the pathogenesis of cancer. The histone deacetylase inhibitors are a new, promising class of anticancer agents. The screening of molecular interactions involving determination of the affinity of drug candidates is an integral part of the drug discovery process. Here we report the development of an assay using surface plasmon resonance for the analysis of HDAC4-small molecule interactions. We describe a new cloning and purification strategy that can be used to set up surface plasmon resonance experiments with other recombinant proteins.

PMID:
18381195
DOI:
10.1016/j.ab.2008.03.028
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center